gptkbp:instanceOf
|
gptkb:biotechnology
|
gptkbp:CEO
|
gptkb:Jože_Colarič
|
gptkbp:country
|
gptkb:Slovenia
|
gptkbp:exportPercentage
|
over 94%
|
gptkbp:founded
|
1954
|
gptkbp:founder
|
gptkb:Government_of_Slovenia
|
gptkbp:headquartersLocation
|
Novo mesto, Slovenia
|
https://www.w3.org/2000/01/rdf-schema#label
|
Krka d.d., Novo mesto
|
gptkbp:industry
|
pharmaceuticals
|
gptkbp:legalForm
|
gptkb:public_company
|
gptkbp:listedOn
|
gptkb:Ljubljana_Stock_Exchange
|
gptkbp:logo
|
Krka logo.svg
|
gptkbp:manufacturingFacilities
|
gptkb:China
gptkb:Croatia
gptkb:Germany
gptkb:Poland
gptkb:Russia
gptkb:Slovenia
other countries
|
gptkbp:market
|
gptkb:Central_Europe
gptkb:Western_Europe
gptkb:Eastern_Europe
gptkb:Southeastern_Europe
Overseas markets
|
gptkbp:namedAfter
|
gptkb:Krka_River
|
gptkbp:netIncome
|
€361 million (2022)
|
gptkbp:notableProduct
|
Atoris (atorvastatin)
Bilobil (ginkgo biloba extract)
Coryol (carvedilol)
Doreta (tramadol/paracetamol)
Enap (enalapril)
Lorista (losartan)
Nolpaza (pantoprazole)
Prenessa (perindopril)
Septolete (throat lozenges)
Sorvasta (rosuvastatin)
Vasilip (simvastatin)
|
gptkbp:numberOfEmployees
|
over 11,000
|
gptkbp:parentCompany
|
none (independent)
|
gptkbp:products
|
animal health products
generic pharmaceuticals
non-prescription products
|
gptkbp:R&DInvestment
|
over €160 million (2022)
|
gptkbp:revenue
|
€1.7 billion (2022)
|
gptkbp:servesArea
|
worldwide
|
gptkbp:stockExchange
|
gptkb:Ljubljana_Stock_Exchange
|
gptkbp:stockSymbol
|
KRKG
|
gptkbp:subsidiary
|
TAD Pharma GmbH
|
gptkbp:website
|
https://www.krka.biz/
|
gptkbp:bfsParent
|
gptkb:Krka_Novo_Mesto
|
gptkbp:bfsLayer
|
8
|